Webcast CME

Series Activities

Series Menu


Visit Virtual Exhibit Hall

Medical Dermatology Therapy Update



Update in Medical Treatment of Autoimmune and Inflammatory Dermatologic Diseases

Print this Content

Release Date:   January 25, 2021
Expiration Date:   January 25, 2023

Estimated Time of Completion:  1 hour and 30 minutes

Description

Medical Dermatology Therapy Update online series will provide a review of traditional therapeutics, as well as biologic and small-molecule therapies, as it applies to a range of important medical dermatologic conditions. In addition it includes an overview of the pathogenesis and diagnosis of various medical dermatologic diseases.

The Update in Medical Treatment of Autoimmune and Inflammatory Dermatologic Diseases webcast will review the following medical conditions: autoimmune bullous diseases, chronic urticaria, inflammatory alopecias, and Cutaneous Sarcoidosis and other Granulomatous Diseases.

Learning Objectives

  1. Describe the major etiologies of drug induced pemphigoid.
  2. List the role of rituximab and omalizumab in the treatment of pemphigoid.
  3. Identify the appropriate use of rituximab in the treatment of pemphigus.
  4. Review presentations of common granulomatous diseases.
  5. Describe when and how to workup for systemic involvement.
  6. Develop treatment approaches and review novel therapeutics.
  7. Review incidence and definition of urticaria and discuss initial treatment options.
  8. Formulate appropriate action plan for patients resistant to initial antihistamine therapy.
  9. Discuss current and future potential treatment options for refractory patients.

Target Audience

These activities are directed to physicians and advanced practice clinicians in dermatology, immunology, oncology, rheumatology, internal medicine, and other health care professionals caring for patients with autoimmune, chronic inflammatory, and advanced malignant diseases.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Activity Director and Faculty

Activity Director

Anthony P. Fernandez, MD, PhD
Director of Medical Dermatology
Department of Dermatology
Dermatology and Plastic Surgery Institute
Cleveland Clinic
Cleveland, OH

Faculty

Wilma Bergfeld, MD
Department of Dermatology
Dermatology and Plastic Surgery Institute
Cleveland Clinic
Cleveland, OH

James Fernandez, MD, PhD
Department of Allergy and Clinical Immunology
Respiratory Institute
Cleveland Clinic
Cleveland, OH

Neil Korman, MD, PhD
Professor, Dermatology
Case Western Reserve University School of Medicine
Director, Murdough Family Center for Psoriasis
Director, Clinical Trials Unit
University Hospitals Cleveland Medical Center
Cleveland, OH

Misha A. Rosenbach, MD
Assistant Professor of Dermatology
Hospital of the University of Pennsylvania
Penn Medicine
Philadelphia, PA

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:


Anthony P. Fernandez, MD, PhD
  AbbVie Pharmaceuticals Consulting
Membership on advisory committee or review panels
Teaching and Speaking
  Celgene Corporation Consulting
  Corbus Pharmaceuticals Research / Independent Contractor
  Mallinckrodt Inc. Consulting
Research / Independent Contractor
Teaching and Speaking
  Novartis Consulting
Research / Independent Contractor
Teaching and Speaking
  Pfizer, Inc. Research / Independent Contractor
  Roche Pharmaceuticals Principal Investigator for a Phase III Clinical Trial
  UCB Consulting
Neil Korman, MD, PhD
  Principia Biopharma Inc. Consulting, Research / Independent Contractor
Misha A. Rosenbach, MD
  Eli Lilly, Janssen Pharmaceuticals, Inc., Merck Consulting
  Processa Pharmaceuticals Consulting, Principal Investigator, Clinical trial with Penn

The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:

Wilma Bergfeld, MD
James Fernandez, MD, PhD


Acknowledgment

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Internet Enduring activity from:

Amgen Inc.
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation


This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education
and the Dermatology and Plastic Surgery Institute.